title: An open-label, sequential dose-escalation, safety, and tolerability study of rimabotulinumtoxinb in subjects with cervical dystonia.
authors.affiliation: Solstice Neurosciences, LLC, Louisville, Kentucky 40207, USA. Robert.Chinnapongse@solsticeneuro.com
authors.forename: Robert
authors.initials: R
authors.lastname: Chinnapongse
authors.forename: Eric J
authors.initials: EJ
authors.lastname: Pappert
authors.forename: Marian
authors.initials: M
authors.lastname: Evatt
authors.forename: Alan
authors.initials: A
authors.lastname: Freeman
authors.forename: William
authors.initials: W
authors.lastname: Birmingham